|
1
|
Xi Y and Xu P: Global colorectal cancer
burden in 2020 and projections to 2040. Transl Oncol.
14:1011742021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Z, Dan W, Zhang N, Fang J and Yang Y:
Colorectal cancer and gut microbiota studies in China. Gut
Microbes. 15:22363642023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He K, Wang Y, Zhong Y, Pan X, Si L and Lu
J: KRAS codon 12 mutation is associated with more aggressive
invasiveness in synchronous metastatic colorectal cancer (mCRC):
Retrospective research. Onco Targets Ther. 13:12601–12613. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van der Jeught K, Xu HC, Li YJ, Lu XB and
Ji G: Drug resistance and new therapies in colorectal cancer. World
J Gastroenterol. 24:3834–3848. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Douillard JY, Cunningham D, Roth AD,
Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J,
Alakl M, et al: Irinotecan combined with fluorouracil compared with
fluorouracil alone as first-line treatment for metastatic
colorectal cancer: A multicentre randomised trial. Lancet.
355:1041–1047. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giacchetti S, Perpoint B, Zidani R, Le
Bail N, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y,
Coudert B, et al: Phase III multicenter randomized trial of
oxaliplatin added to chronomodulated fluorouracil-leucovorin as
first-line treatment of metastatic colorectal cancer. J Clin Oncol.
18:136–147. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee YT, Tan YJ and Oon CE: Molecular
targeted therapy: Treating cancer with specificity. Eur J
Pharmacol. 834:188–196. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohishi T, Kaneko MK, Yoshida Y, Takashima
A, Kato Y and Kawada M: Current targeted therapy for metastatic
colorectal cancer. Int J Mol Sci. 24:17022023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ganesh K, Stadler ZK, Cercek A, Mendelsohn
RB, Shia J, Segal NH and Diaz LA Jr: Immunotherapy in colorectal
cancer: Rationale, challenges and potential. Nat Rev Gastroenterol
Hepatol. 16:361–375. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Overman MJ, Ernstoff MS and Morse MA:
Where we stand with immunotherapy in colorectal cancer: Deficient
mismatch repair, proficient mismatch repair, and toxicity
management. Am Soc Clin Oncol Educ Book. 38:239–247. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Szakács G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dean M, Rzhetsky A and Allikmets R: The
human ATP-binding cassette (ABC) transporter superfamily. Genome
Res. 11:1156–1166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma Y, Guo C, Wang X, Wei X and Ma J:
Impact of chemotherapeutic agents on liver microenvironment:
Oxaliplatin create a pro-metastatic landscape. J Exp Clin Cancer
Res. 42:2372023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CP, Calcagno AM and Ambudkar SV:
Reversal of ABC drug transporter-mediated multidrug resistance in
cancer cells: Evaluation of current strategies. Curr Mol Pharmacol.
1:93–105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li M, Xia M, Zhang Z, Tan Y, Li E, Guo Z,
Fang M, Zhu Y and Hu Z: METTL3 antagonizes 5-FU chemotherapy and
confers drug resistance in colorectal carcinoma. Int J Oncol.
61:1062022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu S, Zhuo L, Wang J, Zhang Q, Li Q, Li
G, Yan L, Jin T, Pan T, Sui X, et al: METTL3 plays multiple
functions in biological processes. Am J Cancer Res. 10:1631–1646.
2020.PubMed/NCBI
|
|
17
|
El-Shami K, Oeffinger KC, Erb NL, Willis
A, Bretsch JK, Pratt-Chapman ML, Cannady RS, Wong SL, Rose J,
Barbour AL, et al: American cancer society colorectal cancer
survivorship care guidelines. CA Cancer J Clin. 65:428–455. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pachman DR, Qin R, Seisler DK, Smith EML,
Beutler AS, Ta LE, Lafky JM, Wagner-Johnston ND, Ruddy KJ, Dakhil
S, et al: Clinical course of oxaliplatin-induced neuropathy:
Results from the randomized phase III trial N08CB (alliance). J
Clin Oncol. 33:3416–3422. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JF, Wu SW, Shi ZM and Hu B:
Traditional Chinese medicine for colorectal cancer treatment:
Potential targets and mechanisms of action. Chin Med. 18:142023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Y, Wu H, Wang X, Wang C, Gan L, Zhu
J, Tong J and Li Z: Huaier Granule extract inhibit the
proliferation and metastasis of lung cancer cells through
down-regulation of MTDH, JAK2/STAT3 and MAPK signaling pathways.
Biomed Pharmacother. 101:311–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu B, Yan W, Wang M, Cui X, Hu Y, Chen Q,
Zhang Y, Qi X and Jiang J: Huaier polysaccharide inhibits the
stem-like characteristics of ERα-36high triple negative
breast cancer cells via inactivation of the ERα-36 signaling
pathway. Int J Biol Sci. 15:1358–1367. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Liu C, Yan K, Liu J, Fang Z and Fan
Y: Huaier extract inhibits prostate cancer growth via targeting
AR/AR-V7 pathway. Front Oncol. 11:6155682021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Su D, Jiang B, Yang Y, Miao Y, Fu Q and
Zhang F: Effect of Huaier on melanoma invasion, metastasis, and
angiogenesis. Biomed Res Int. 2020:81638392020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan J, Yang C, Jiang Z and Huang J:
Trametes robiniophila Murr: A traditional Chinese medicine with
potent anti-tumor effects. Cancer Manag Res. 11:1541–1549. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu DQ, Yuan XJ, Toyoda H and Hirayama M:
Anti-tumor effect of Huaier extract against neuroblastoma cells in
vitro. Int J Med Sci. 18:1015–1023. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji D, Zheng W, Huang P, Yao Y, Zhong X,
Kang P, Wang Z, Shi G, Xu Y and Cui Y: Huaier restrains
cholangiocarcinoma progression in vitro and in vivo through
modulating lncRNA TP73-AS1 and inducing oxidative stress. Onco
Targets Ther. 13:7819–7837. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo Z, Hu X, Xiong H, Qiu H, Yuan X, Zhu
F, Wang Y and Zou Y: A polysaccharide from Huaier induced apoptosis
in MCF-7 breast cancer cells via down-regulation of MTDH protein.
Carbohydr Polym. 151:1027–1033. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu Z, Yang A, Fan H, Wang Y, Zhao Y, Zha
X, Zhang H and Tu P: Huaier aqueous extract sensitizes cells to
rapamycin and cisplatin through activating mTOR signaling. J
Ethnopharmacol. 186:143–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang L, Zhang Y, Zang Y, Chai R, Zhong G,
Li Z, Duan Z, Ren J and Xu Z: HP-1 inhibits the progression of
ccRCC and enhances sunitinib therapeutic effects by suppressing
EMT. Carbohydr Polym. 223:1151092019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan X, Lyu T, Jia N, Yu Y, Hua K and Feng
W: Huaier aqueous extract inhibits ovarian cancer cell motility via
the AKT/GSK3β/β-catenin pathway. PLoS One. 8:e637312013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Siegel RL, Wagle NS, Cercek A, Smith RA
and Jemal A: Colorectal cancer statistics, 2023. CA Cancer J Clin.
73:233–254. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Z, Zhang X, Bai X, Xi X, Liu W and
Zhong W: Anti-angiogenesis in colorectal cancer therapy. Cancer
Sci. 115:734–751. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu T, Guo F, Yu Y, Sun T, Ma D, Han J,
Qian Y, Kryczek I, Sun D, Nagarsheth N, et al: Fusobacterium
nucleatum promotes chemoresistance to colorectal cancer by
modulating autophagy. Cell. 170:548–563.e16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Visvanathan A, Patil V, Arora A, Hegde AS,
Arivazhagan A, Santosh V and Somasundaram K: Essential role of
METTL3-mediated m6A modification in glioma stem-like
cells maintenance and radioresistance. Oncogene. 37:522–533. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peng W, Li J, Chen R, Gu Q, Yang P, Qian
W, Ji D, Wang Q, Zhang Z, Tang J and Sun Y: Upregulated METTL3
promotes metastasis of colorectal cancer via miR-1246/SPRED2/MAPK
signaling pathway. J Exp Clin Cancer Res. 38:3932019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu X, Su K, Sun X, Jiang Y, Wang L, Hu C,
Zhang C, Lu M, Du X and Xing B: Sec62 promotes stemness and
chemoresistance of human colorectal cancer through activating
Wnt/β-catenin pathway. J Exp Clin Cancer Res. 40:1322021.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kong MY, Li LY, Lou YM, Chi HY and Wu JJ:
Chinese herbal medicines for prevention and treatment of colorectal
cancer: From molecular mechanisms to potential clinical
applications. J Integr Med. 18:369–384. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yan Z, Lai Z and Lin J: Anticancer
properties of traditional Chinese medicine. Comb Chem High
Throughput Screen. 20:423–429. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Y, Liu X, Yu M, Xu M, Xiao Y, Ma W,
Huang L, Li X and Ye X: Berberine inhibits proliferation and
induces G0/G1 phase arrest in colorectal cancer cells by
downregulating IGF2BP3. Life Sci. 260:1184132020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qiao L, Han M, Gao S, Shao X, Wang X, Sun
L, Fu X and Wei Q: Research progress on nanotechnology for delivery
of active ingredients from traditional Chinese medicines. J Mater
Chem B. 8:6333–6351. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou C, Li J, Qian W, Yue Y, Xiao Y, Qin
T, Ma Q and Li X: Huaier extract restrains pancreatic cancer by
suppressing Wnt/β-catenin pathway. Biomed Pharmacother.
127:1101262020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun WW, Dou JX, Zhang L, Qiao LK, Shen N,
Zhao Q and Gao WY: Killing effects of Huaier Granule combined with
DC-CIK on nude mice transplanted with colon carcinoma cell line.
Oncotarget. 8:46081–46089. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cong L, Shi J, Zhao J, Li K, Dai D, Zhang
B and Zhao W: Huaier inhibits cholangiocarcinoma cells through the
twist1/FBP1/Wnt/β-catenin axis. Mol Biol Rep. 51:8422024.
View Article : Google Scholar : PubMed/NCBI
|
